We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Psychedelics – News and Features

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD.
News

Scientists Redesign LSD To Create a Non-Hallucinogenic Antidepressant

UC Davis researchers developed JRT, a modified version of LSD that promotes neuroplasticity without hallucinogenic effects. Tested in mice, JRT enhanced brain connectivity, showed antidepressant effects and improved cognition.
A person lying down in a relaxed state, possibly practicing mindfulness or meditation, with soft lighting, reflecting the tranquil impact of psychedelics on the mind.
News

Psilocybin’s Therapeutic Effects Linked to Specific Brain Pathways

Cornell researchers found that psilocybin’s therapeutic benefits depend on the pyramidal tract neurons and the serotonin 5-HT2A receptor in the medial frontal cortex. Targeting these mechanisms could allow psilocybin to treat depression.
Person lying peacefully on the floor in dim light, evoking a meditative or psychedelic therapy experience.
News

Psychedelics’ Influence on Gender Identity and Sexual Experiences

A study found that psychedelic experiences enhanced relationship quality, sexual attraction and intimacy. Participants reported both short- and long-term benefits, with some experiencing changes in gender identity.
A person using tweezers to handle tiny drug strips on their fingertip, symbolizing the concept of microdosing LSD for controlled substance intake.
News

Microdosing LSD Fails To Improve ADHD Symptoms

A recent study challenges the effectiveness of microdosing LSD for treating ADHD. Despite self-reported improvements, the clinical trial found no significant difference between low-dose LSD and placebo in reducing ADHD symptoms.
A brain, with sections lit up in multi-colored lights.
News

New Insights Into How Psilocybin Promotes Neural Cell Growth

A single dose of psilocin can induce changes in human nerve cells, providing researchers with a better understanding of the mechanisms behind psilocin's effects.
A woman laying on the floor looking at peace.
News

Study Examines Evidence for MDMA Therapy in PTSD Treatment

A Monash-led study evaluated MDMA-assisted psychotherapy (MDMA-AP) for PTSD, finding symptom improvement but low-certainty evidence. The findings will inform Australia’s first clinical guidelines on MDMA-AP.
Ketamines chemical molecules (yellow) can bind to a specific part (the gray web) of the brain receptor.
News

NMDA Receptor Discovery Advances Understanding of Ketamine’s Effects

Cold Spring Harbor Laboratory researchers confirm the existence of GluN1-2B-2D, a brain receptor targeted by ketamine. Using cryo-EM, they visualize how ketamine binds to the receptor, controlling its ion channel activity.
A cell, with a clear cell membrane and blue interior.
News

How Cells Recycle Important Fat Molecules To Stay Healthy

New research has made a breakthrough in understanding how our cells manage to stay healthy by recycling important fat molecules.
A human brain.
News

Low Doses of Oral Ketamine Can Reduce PTSD Symptoms, Study Suggests

A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in symptoms. The treatment, taken as a liquid drink, was well-tolerated and had fewer side effects than intravenous ketamine.
A person holding mushrooms.
News

Psychedelic Therapy May Help Improve Cancer Patients’ Mental Health

The “magic mushroom” psychedelic compound – psilocybin – may help to improve mental health symptoms faced by cancer patients when used alongside psychotherapy.
Advertisement